Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,609
Closed -$1.61M 452
2022
Q2
$1.61M Buy
+6,609
New +$1.62M 0.02% 231
2022
Q1
Sell
-6,608
Closed -$1.49M 487
2021
Q4
$1.49M Buy
+6,608
New +$1.39M 0.01% 294
2021
Q1
Sell
-980
Closed -$225K 535
2020
Q4
$225K Buy
+980
New +$226K ﹤0.01% 493
2020
Q2
Sell
-13,641
Closed -$2.77M 434
2020
Q1
$2.77M Buy
13,641
+13,301
+3,912% +$2.91M 0.05% 132
2019
Q4
$82K Buy
+340
New +$74.9K ﹤0.01% 426
2019
Q3
Sell
-481
Closed -$88.6K 450
2019
Q2
$88.6K Buy
+481
New +$86.1K ﹤0.01% 413
2019
Q1
Sell
-14,587
Closed -$2.84M 433
2018
Q4
$2.84M Hold
14,587
0.05% 166
2018
Q3
$3.02M Sell
14,587
-3,465
-19% -$683K 0.04% 174
2018
Q2
$3.33M Sell
18,052
-9,509
-35% -$1.68M 0.04% 189
2018
Q1
$4.7M Sell
27,561
-61,288
-69% -$11.3M 0.06% 174
2017
Q4
$15.5M Buy
88,849
+4,962
+6% +$878K 0.2% 84
2017
Q3
$15.7M Buy
83,887
+14,447
+21% +$2.56M 0.2% 85
2017
Q2
$12M Buy
+69,440
New +$11.3M 0.17% 97

Other funds holding AMGN

Pendal Group's AMGN Position: Q3 2022 in Review

Pendal Group sold out of Amgen (AMGN) in Q3 2022, closing a stake of 6,609 shares — an estimated $1.61M sold.

Pendal Group first reported a position in AMGN in Q2 2017 and held it in 13 quarters. The position peaked at $15.7M in Q3 2017. 2,323 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

  • Pendal Group reported no remaining Amgen position as of Q3 2022 after selling out during the quarter.
  • Pendal Group sold 6,609 Amgen shares in Q3 2022, an estimated $1.61M.
  • Pendal Group first reported a position in Amgen in Q2 2017 and held it in 13 quarters.
  • Pendal Group's Amgen position peaked at $15.7M in Q3 2017.
  • 2,323 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Pendal Group's 13F filing for Q3 2022, filed 18 Oct 2022.